Skip Navigation LinksHome > October 1, 2012 - Volume 61 - Issue 2 > Use of Zidovudine-Sparing HAART in Pregnant HIV-Infected Wom...
Text sizing:
A
A
A
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e3182724e2e
Errata

Use of Zidovudine-Sparing HAART in Pregnant HIV-Infected Women in Europe: 2000-2009: Erratum.

Free Access

In the article by Tariq et al, appearing in the Journal of Acquired Immune Deficiency Syndromes, Vol 57, No. 4, pp. 326-333 entitled “Use of Zidovudine-Sparing HAART in Pregnant HIV-Infected Women in Europe: 2000-2009,” there is an error in the figure on page 330. The key currently reads “Proportion of pregnant women initiated on ZDV during pregnancy” and “Proportion of pregnant women on ZDV at conception”. This should read “Proportion of pregnant women initiated on ZDV-sparing HAART during pregnancy” and “Proportion of pregnant women on ZDV-sparing HAART at conception”.

Back to Top | Article Outline

REFERENCE

Tariq S, Townsend C, Cortina-Borja M, et al.. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr. 2011;57:326–333.

© 2012 Lippincott Williams & Wilkins, Inc.

Login